Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Effects of age on angiotensin II response and antagonistic activity of losartan in rat aorta and liver

  • Jung, Yi-Sook (Pharmaceutical Screening Center, Korea Research Institute of Chemical Technology(KRICT)) ;
  • Lee, Sung-Hou (Pharmaceutical Screening Center, Korea Research Institute of Chemical Technology(KRICT)) ;
  • Shin, Hwa-Sup (Pharmaceutical Screening Center, Korea Research Institute of Chemical Technology(KRICT))
  • Published : 1996.12.01
Download PDF
⟨ Previous Next ⟩

Abstract

The present study was undertaken to investigate the effects of age on angiotensin II (AII) response and antagonistic activity of losartan using aortic rings and liver homogenates from rats ranging in age from 0.7 to 20 months. Whether the endothelium was present or not, the maximum contractile response to AII decreased with age. Removal of the endothelium enhanced AII-induced maximum contraction and these endothelial effects seemed to be due to endothelium-derived relaxing factor (EDRF) in all ages. Equilibrium binding studies demonstrated an age-related decrease in maximum binding $(B_{max})$ with little change in binding affinity $(K_d)$. In rat aorta, the extent of losartan-induced parallel shifts $(K_B)$ in AII concentration-response curves was not significantly different between ages. In addition, $IC_{50}$ value of losartan in competition binding was not changed with age in rat liver homogenates. These results suggest that the potency of losartan is not altered with age in rat aorta and liver, although AII-induced contractile response and the maximum AII binding decreased significantly with age.

Keywords

References

  1. Mol. Pharmacol. v.39 DuP 753 can antagonize the effects of angiotensin Ⅱ in rat liver Bauer,P.H.;Chiu,A.T.;Garrison,J.C.
  2. Br. J. Pharmac. v.89 Influence of the vascular endothelium on agonist-induced contractions and relaxations in rat aorta Bullock,G.R.;Taylor,S.G.;Weston,A.H.
  3. J. Pharmacol. Exp. Ther. v.252 no.2 Non-peptide angiotensin Ⅱ receptor antagonist. Ⅷ. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent Chiu,A.T.;McCall,D.E.;Price,W.A.;Wong,P.C.;Carini,D.J.;Duncia,J.V.;Wexler,R.R.;Yoo,S.E.;Johnson,A.L.;Timmermans,P.B.M.W.M.
  4. J. Biol. Chem. v.253 Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins Craven,P.A.;De Rubertis,R.F.
  5. J. Auton. Pharmac. v.6 Aging and the cardiovascular system Docherty,J.R.
  6. Pharmac. Ther. v.8 Age-related changes in the sensitivity of blood vessels to drugs Fleisch,J.H.
  7. Cell Biochem. Funct. v.6 Angiotensin II vascular receptors I fetal and neonatal rats Ghiani,P.;Uva,B.M.;Mandich,A.;Masini,M.A.
  8. J. Biol. Chem. v.249 Properties of angiotensin Ⅱ receptors in the bovine and rat adrenal cortex Glossman,H.;Baukal,A.J.;Catt,K.J.
  9. Eur. J. Pharmacol. v.146 Endothelium-dependent modulation of angiotensin II-induced contraction in blood vessels Gruetter,C.A.;Ryan,E.T.;Lemke,S.M.;Bailly,D.A.;Fox,M.K.;Schoepp,D.D.
  10. Circ. Res. v.47 Identification and characterization of the high affinity vascular angiotensin II receptor in rat mesenteric artery Gunther,S.;Gimbone,M.A.,Jr.;Alexander,R.W.
  11. Arch. Pharm. Res. v.13 no.2 Differential vasorelaxant effects of KR-30075, a new cyclic AMP-phosphodiesterase inhibitor, on guinea-pig pulmonary, bovine coronary and renal arteries Jung,Y.S.;Kwon,K.I.;Zee,O.P.
  12. J. Endocrinol. Invest. v.14 Ontogeny of angiotensinogen mRNA and angiotensin II receptors in rat brain and liver Kalinyak,J.E.;Hoffman,A.R.;Perlamn,A.J.
  13. J. Cardiovasc. Pharmacol. v.21 Actions of norepinephrine and angiotensin II on aortic rings of adult and aged normotensive and hypertensive rats Kuttan,S.C.;Sim,M.K.
  14. Arch. Pharm. Res. v.18 no.3 Effect of age on angiotensin II receptor binding in rat liver Lee,S.;Jung,Y.S.;Kong,J.
  15. J. Pharmacol. Exp. Ther. v.233 no.3 Blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation of rabbit aorta by certain ferrous hemoproteins Martin,W.;Villani,G.M.;Jothianadan,D.;Furchgott,R.F.
  16. J. Pharmacol. Exp. Ther. v.232 Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rab-bit aorta Martin,W.;Villani,G.M.;Jothianadan,D.;Furchgott,R.F.
  17. J. Pharmacol. Exp. Ther. v.228 Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats O'Donnell,S.R.;Wanstall,J.C.
  18. Life Sci. v.53 Age, endothelium and aortic reactivity to calcium in wistar rat Overloop,B.V.;Stoclet,J.C.;Gairard,A.
  19. Physiol. Rev. v.57 Renin-angiotensin system: Biochemistry and mechanisms of action Peach,M.J.
  20. J. Biol. Chem. v.260 Role of Ni in coupling angiotensin receptors to inhibition of adenylate cyclase in hepatocytes Pobiner,B.F.;Hewlett,E.L.;Garrison,J.C.
  21. J. Mol. Cell Cardiol. v.23 Angiotensin II binding protein in adult and neonatal rat heart Sen,I.;Rajasekaran,A.K.
  22. Am. J. Physiol. v.266 no.6 Altered renal vascular responses in the aging rat kidney Tank,J.E.;Vora,J.P.;Houghton,D.C.;Anderson,S.
  23. J. Pharmacol. Exp. Ther. v.239 no.2 Age-related decrease in beta adrenergic receptor-mediated vascular smooth muscle relaxation Tsujimoto,G.;Lee,C.H.;Hoffman,B.B.
  24. Biochem. Biophy. Res. Comm. v.179 Changes in expression of angiotensin receptor subtypes in the rat aorta during development Viswanathan,M.;Tsutsumi,K.;Correa,F.M.A.;Saavedra,J.M.
  25. Life Sci. v.47 Effect of age on contractile response to angiotensin II in rat aorta Wakabayashi,I.;Sakamoto,K.;Hatake,K.;Yoshimoto,S.;Kurahashi,M.
  26. Eur. J. Pharmacol. v.159 Influence of age on calcium entry blocking drugs in rat aorta is spasmogen-dependent Wanstall,J.C.;O'Donnell,S.R.
  27. J. Pharmacol. Exp. Ther. v.245 no.3 Inhibition of norepinephrine contraction by diltiazem on aorta and pulmonary artery from young and aged rats: influences of alpha-adrenoceptor reserve Wanstall,J.C.;O'Donnell,S.R.
  28. J. Pharmacol. Exp. Ther. v.252 no.2 Nonpeptide angiotensin II receptor antagonists. Ⅸ. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent Wong,P.C.;Price,W.A.;Chiu,A.T.;Duncia,J.V.;Carini,D.J.;Wexler,R.R.;Johnson,A.L.;Timmermans,P.B.M.W.M.